Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: P2C 9271 Principal Investigator: Bartlett, Nancy
Title: Phase 2 Trial of Single-Agent Ibrutinib (PCI-32765) in Relapsed or Refractory Follicular Lymphoma
Phase: II Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to find out what effects, good and/or bad, ibrutinib has on the patient and their follicular lymphoma. This study focuses on patients who have follicular lymphoma that is no longer responding to rituximab treatment.
 
More Information:
CT.gov link
Internal Protocol Documents (requires Siteman administrative database password)